NCT06682923

Brief Summary

This is a prospective, single-arm, paired clinical evaluation of the MolecuLightDX device in the measurement of surface wounds in patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2024

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2025

Completed
Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

November 7, 2024

Last Update Submit

June 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean and SD of percent error for wound area by the MLI device in manual and automatic modes and by ruler

    up to 6 months

Secondary Outcomes (1)

  • Mean and standard deviation of inter- and intra-user coefficient of variation (CV) for wound area measured by the MolecuLight device in manual and automaitc modes

    up to 6 months

Interventions

The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults 22 years and older with surface wounds

You may qualify if:

  • Willing to consent
  • Willing to comply with all study procedures and availability for the duration of the study
  • Male or female, aged over 22 years old
  • Presented with diabetic foot ulcers, venous, arterial and pressure ulcers
  • Wound size is greater than 0.5 cm2
  • The wound has well-defined wound borders

You may not qualify if:

  • Circumferential wound
  • Wound without clearly defined wound borders
  • Wound located in a difficult to reach/measure location
  • Any contra-indication to routine wound care and/or monitoring
  • Wounds with a length greater than 18.5cm or a width greater than 13.5cm.
  • Tunneled or undermined wounds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Mayer Institute

Hamilton, Ontario, L8R 2R3, Canada

Location

Judy Dan Centre for Hyperbaric Medicine & Advance Wound Care

North York, Ontario, M2R 1N5, Canada

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2024

First Posted

November 12, 2024

Study Start

October 23, 2024

Primary Completion

February 20, 2025

Study Completion

February 20, 2025

Last Updated

June 25, 2026

Record last verified: 2026-06

Locations